Get the Stockscreener App
20.93
2.55%
0.52
After Hours:
20.93
Ceribell Inc stock is traded at $20.93, with a volume of 330.85K.
It is up +2.55% in the last 24 hours and up +62.88% over the past month.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
See More
Previous Close:
$20.41
Open:
$20.49
24h Volume:
330.85K
Relative Volume:
0.89
Market Cap:
$776.41M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+6.14%
1M Performance:
+62.88%
6M Performance:
+15.13%
1Y Performance:
-28.32%
1-Day Range:
$20.20
$21.07
1-Week Range:
$19.52
$24.25
52-Week Range:
$10.01
$29.96
Ceribell Inc Stock (CBLL) Company Profile
Name
Ceribell Inc
Sector
Industry
Phone
(800) 436-0826
Address
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
20.93 | 757.12M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Initiated | Raymond James | Strong Buy |
| Jun-24-25 | Initiated | BTIG Research | Buy |
| Apr-04-25 | Initiated | Ladenburg Thalmann | Buy |
| Nov-05-24 | Initiated | BofA Securities | Buy |
| Nov-05-24 | Initiated | Canaccord Genuity | Buy |
| Nov-05-24 | Initiated | JP Morgan | Overweight |
| Nov-05-24 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Initiated | William Blair | Outperform |
View All
Ceribell Inc Stock (CBLL) Latest News
Ceribell extends leases for Sunnyvale offices through January 2028 By Investing.com - Investing.com Nigeria
FDA Clears Ceribell’s AI-Powered EEG as First Device for Continuous Delirium Monitoring - HIT Consultant
Ceribell, Inc. Extends Sunnyvale Office Leases - TipRanks
Ceribell extends leases for Sunnyvale offices through January 2028 - Investing.com
CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring Solution - TradingView
Ceribell receives FDA 510K clearance for delirium screening, monitoring device - MSN
Risk Analysis: Will CeriBell Inc stock split attract more investorsEarnings Miss & Verified Short-Term Trading Plans - moha.gov.vn
Ceribell director Robertson sells $100k in CBLL stock By Investing.com - Investing.com South Africa
Ceribell director Robertson sells $100k in CBLL stock - Investing.com
FDA OKs Ceribell’s Delirium Monitoring Solution - Medical Product Outsourcing
Buy Rating Affirmed for Ceribell, Inc. Due to Innovative Neonate Technology and FDA Clearance - TipRanks
Ceribell, Inc.’s Delirium Solution Gains Early FDA Clearance, Boosting Market Potential and Supporting Buy Rating - TipRanks
There's Reason For Concern Over CeriBell, Inc.'s (NASDAQ:CBLL) Massive 69% Price Jump - 富途牛牛
Ceribell stock price target raised to $29 from $20 at TD Cowen on FDA clearance - Investing.com
CeriBell Says FDA Clears Delirium Monitoring Solution; Shares Rise - marketscreener.com
Ceribell, Inc. Gains FDA Clearance for Delirium Device - TipRanks
Ceribell jumps on FDA clearance of brain monitoring device - TradingView
Ceribell, Inc. Receives FDA Clearance for Delirium Monitoring Solution - TradingView
Ceribell receives FDA 510k clearance for delirium screening, monitoring device - TipRanks
FDA clears Ceribell’s delirium monitoring system for ICU patients By Investing.com - Investing.com India
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution - The Manila Times
Ceribell (Nasdaq: CBLL) gets FDA 510(k) clearance for first delirium monitoring device - Stock Titan
Ceribell CEO Chao Xingjuan sells $470k in CBLL stock By Investing.com - Investing.com Canada
CeriBell (NASDAQ:CBLL) CEO Sells $470,500.00 in Stock - MarketBeat
Ceribell CEO Chao Xingjuan sells $470k in CBLL stock - Investing.com
Ceribell Insider Sold Shares Worth $470,500, According to a Recent SEC Filing - marketscreener.com
David Foehr Sells 5,265 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Ceribell’s Foehr David sells $88k in Ceribell stock By Investing.com - Investing.com Australia
Ceribell’s Foehr David sells $88k in Ceribell stock - Investing.com India
Ceribell Senior VP David Foehr Sells 5,265 Shares - TradingView
VP Foehr Sells 5,265 ($88.6K) Of CeriBell Inc [CBLL] - TradingView
Insider Selling: CeriBell (NASDAQ:CBLL) Director Sells 827 Shares of Stock - MarketBeat
Geode Capital Management LLC Has $8.39 Million Stock Position in CeriBell, Inc. $CBLL - MarketBeat
CEO Chao Files To Sell 25,000 Of CeriBell Inc [CBLL] - TradingView
Robertson of Ceribell sells $13k in shares By Investing.com - Investing.com Nigeria
Insider Selling: CeriBell (NASDAQ:CBLL) CEO Sells 25,000 Shares of Stock - MarketBeat
CeriBell (NASDAQ:CBLL) CTO Sells $136,455.36 in Stock - MarketBeat
Robertson of Ceribell sells $13k in shares - Investing.com
Ceribell Director Rebecca B. Robertson Sells 827 Shares - TradingView
Chmn Robertson Sells 827 ($13.8K) Of CeriBell Inc [CBLL] - TradingView
CeriBell, Inc. (CBLL) Presents at Piper Sandler 37th Annual Healthcare ConferenceSlideshow - Seeking Alpha
Ceribell management to meet virtually with BTIG - MSN
Ceribell’s Woo Raymond sells $136k in shares By Investing.com - Investing.com Australia
Ceribell’s Woo Raymond sells $136k in shares - Investing.com
Ceribell Insider Sold Shares Worth $414,750, According to a Recent SEC Filing - marketscreener.com
Officer Woo Sells 11,112 ($184.5K) Of CeriBell Inc [CBLL] - TradingView
CEO Chao Sells 25,000 ($414.8K) Of CeriBell Inc [CBLL] - TradingView
CBLL: AI-driven EEG platform posts robust growth, expands indications, and demonstrates clinical impact - TradingView
Aug Sectors: Is CeriBell Inc stock a buy on dipsMarket Weekly Review & Weekly Chart Analysis and Guides - BỘ NỘI VỤ
Chmn Robertson Files To Sell 827 Of CeriBell Inc [CBLL] - TradingView
CeriBell (CBLL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Ceribell Inc Stock (CBLL) Financials Data
There is no financial data for Ceribell Inc (CBLL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.52%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):